Financhill
Back

Arvinas 10K Form

Sell
50

ARVN
Arvinas

Last Price:
32.69
Seasonality Move:
-6.12%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

Receive ARVN News And Ratings

See the #1 stock for the next 7 days that we like better than ARVN

ARVN Financial Statistics

Sales & Book Value

Annual Sales: $78.5M
Cash Flow: $-83.2M
Price / Cash Flow: 0
Annual Sales: $9.71
Price / Book: 3.51

Profitability

EPS (TTM): -6.50000
Net Income (TTM): $-367.3M
Gross Margin: --
Return on Equity: -69.13%
Return on Assets: -31.18%

Arvinas Earnings Forecast

Key Arvinas Financial Ratios

  • The Research & Development expenses have been 483.69% of Revenue.
  • The Interest Expense is -0.05% of Operating Income.
  • The Net Earning history of ARVN is -467.90% of Total Revenues.
  • Per Share Earnings over the last 8 years have been positive in 1 years.

Arvinas Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: ARVN
CUSIP: 04335A
Website: arvinas.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 4.98
Quick Ratio: 4.93

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

ARVN Technical Analysis vs Fundamental Analysis

Sell
50
Arvinas (ARVN) is a Sell

Is Arvinas a Buy or a Sell?

  • Arvinas stock is rated a Sell
    The current Arvinas [ARVN] share price is $34.00. The Score for ARVN is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.